News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
KIES PETER
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/17/2023 |
4
| KIES PETER (CFO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Granted 171,756 restricted stock units
@ $0 |
|
| 03/13/2023 |
4
| KIES PETER (CFO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 31,410 shares
@ $1.13, valued at
$35.5k
Exercised 59,737 restricted stock units
@ $0 |
|
| 02/28/2023 |
4
| KIES PETER (CFO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 12,928 shares
@ $1.28, valued at
$16.5k
Paid exercise price by delivering 28,195 shares
@ $1.28, valued at
$36.1k
Exercised 22,544 restricted stock units
@ $0
Exercised 47,967 restricted stock units
@ $0
Granted 225,000 options
@ $1.24, valued at
$279k
|
|
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2020 |
4
| KIES PETER (CFO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Exercised 8,750 shares
@ $2.4, valued at
$21k
Exercised 11,250 shares
@ $2.16, valued at
$24.3k
Sold 20,000 shares
@ $10.6853, valued at
$213.7k
Exercised 8,750 options
@ $0
Exercised 11,250 options
@ $0 |
|
| 07/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2019 |
4
| KIES PETER (CFO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 8,591 shares
@ $3.34, valued at
$28.7k
Paid exercise price by delivering 7,066 shares
@ $3.34, valued at
$23.6k
Exercised 25,000 restricted stock units
@ $0
Exercised 20,433 restricted stock units
@ $0
Granted 100,500 options
@ $3.34, valued at
$335.7k
Granted 64,400 restricted stock units
@ $0 |
|
| 03/07/2019 |
4
| KIES PETER (CFO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 10,301 shares
@ $3.61, valued at
$37.2k
Exercised 27,567 restricted stock units
@ $0 |
|
| 11/30/2018 |
4
| KIES PETER (CFO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Exercised 10,001 shares
@ $2, valued at
$20k
Sold 10,001 shares
@ $5.28, valued at
$52.8k
Exercised 10,001 options
@ $0 |
|
| 07/11/2018 |
4
| KIES PETER (CFO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Exercised 15,000 shares
@ $4.24, valued at
$63.6k
Sold 25,000 shares
@ $4.43, valued at
$110.8k
Sold 10,000 shares
@ $4.45, valued at
$44.5k
Exercised 15,000 options
@ $0 |
|
| 03/13/2018 |
4
| KIES PETER (CFO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 8,421 shares
@ $4.51, valued at
$38k
Paid exercise price by delivering 6,899 shares
@ $4.51, valued at
$31.1k
Exercised 25,000 restricted stock units
@ $0
Exercised 20,434 restricted stock units
@ $0 |
|
| 03/07/2018 |
4
| KIES PETER (CFO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 3,407 shares
@ $4.29, valued at
$14.6k
Exercised 8,333 restricted stock units
@ $0
Granted 126,500 options
@ $4.29, valued at
$542.7k
Granted 82,700 restricted stock units
@ $0 |
|
| 03/13/2017 |
4
| KIES PETER (CFO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 9,171 shares
@ $6.61, valued at
$60.6k
Exercised 25,000 restricted stock units
@ $0
Granted 100,000 options
@ $6.68, valued at
$668k
Granted 61,300 restricted stock units
@ $0 |
|
| 03/07/2017 |
4
| KIES PETER (CFO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 3,640 shares
@ $6.95, valued at
$25.3k
Exercised 8,333 restricted stock units
@ $0 |
|
| 03/11/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/18/2013 |
4
| KIES PETER (CFO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Granted 180,000 options to buy
@ $0.54, valued at
$97.2k
|
|
| 06/05/2012 |
4
| KIES PETER (CFO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Bought 25,000 shares
@ $0.41, valued at
$10.3k
|
|
| 02/27/2012 |
4
| KIES PETER (CFO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Granted 175,000 options to buy
@ $0.6, valued at
$105k
|
|
| 06/24/2011 |
4
| KIES PETER (CFO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Bought 24,000 shares
@ $0.5676, valued at
$13.6k
|
|
| 03/14/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/02/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|